Health Canada drug identification number

DIN 02481901 — TARO-CIPROFLOXACIN/DEXAMETHASONE 0.1 %; 0.3 %

TARO-CIPROFLOXACIN/DEXAMETHASONE is a suspension of Ciprofloxacin / Dexamethasone marketed by TARO PHARMACEUTICALS INC. The full Ciprofloxacin / Dexamethasone monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02481901
Brand name
TARO-CIPROFLOXACIN/DEXAMETHASONE
Strength
0.1 %; 0.3 %
Dosage form
SUSPENSION
Route
OTIC
Manufacturer
TARO PHARMACEUTICALS INC
Health Canada status
MARKETED
Drug class
Fluoroquinolone antibiotic / corticosteroid combination (otic)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Ciprofloxacin / Dexamethasone products

DINBrandStrengthFormManufacturerStatus
02252716 CIPRODEX 0.3 %; 0.1 % SUSPENSION NOVARTIS PHARMACEUTICALS CANADA INC MARKETED
02506882 SANDOZ CIPROFLOXACIN / DEXAMETHASONE 0.3 %; 0.1 % SUSPENSION SANDOZ CANADA INCORPORATED MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.